Hostname: page-component-7c8c6479df-995ml Total loading time: 0 Render date: 2024-03-29T01:15:31.928Z Has data issue: false hasContentIssue false

A Double Blind Comparative Trial of Pericyazine and Thioridazine in Chronic Schizophrenia

Published online by Cambridge University Press:  29 January 2018

J. G. Barker
Affiliation:
Shelton Hospital, Shrewsbury, Shropshire
Mabel Miller
Affiliation:
Shelton Hospital, Shrewsbury, Shropshire

Extract

Pericyazine (“Neulactil”), introduced in 1961, is a phenothiazine with tranquillizing and stimulating properties.

Type
Studies in Schizophrenia
Copyright
Copyright © Royal College of Psychiatrists, 1969 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Heller, G. C., and Mather, M. D. (1965). Proceedings of the Leeds Symposium on Behavioural Disorders (ed. Jenner, F. A., Dagenham, 80.Google Scholar
Leitch, A. (1965). Ibid., 121.Google Scholar
Wilson, J. D., and Enoch, M. D. (1967). “Estimation of drug rejection by schizophrenic in-patients with analysis of clinical factors.” Brit. J. Psychiat., 113, 209211.CrossRefGoogle Scholar
Wing, J. K. (1961). “A simple and reliable sub-classification of chronic schizophrenia.” J. ment. Sci., 107, 862.CrossRefGoogle Scholar
Submit a response

eLetters

No eLetters have been published for this article.